Putamen hypertrophy in nondemented patients with human immunodeficiency virus infection and cognitive compromise.
about
Neurocognitive correlates of alexithymia in asymptomatic individuals with HIVRole of neuroimaging in HIV-associated neurocognitive disordersNeuroimaging of HIV-associated neurocognitive disorders (HAND)Evidence for predilection of macrophage infiltration patterns in the deeper midline and mesial temporal structures of the brain uniquely in patients with HIV-associated dementiaViral parkinsonism.Remote semantic memory for public figures in HIV infection, alcoholism, and their comorbidityOsteopontin expression in the brain triggers localized inflammation and cell death when immune cells are activated by pertussis toxin.Impact of the HIV Tat C30C31S dicysteine substitution on neuropsychological function in patients with clade C disease.The role of medical imaging in defining CNS abnormalities associated with HIV-infection and opportunistic infectionsSubcortical brain atrophy persists even in HAART-regulated HIV disease.Subcortical shape and volume abnormalities in an elderly HIV+ cohort.Focal cortical and subcortical atrophy in early Parkinson's diseaseMAPPING ABNORMAL SUBCORTICAL BRAIN MORPHOMETRY IN AN ELDERLY HIV+ COHORT.Regional brain structural dysmorphology in human immunodeficiency virus infection: effects of acquired immune deficiency syndrome, alcoholism, and ageDistal sensory polyneuropathy is associated with neuropsychological test performance among persons with HIV.Effects of HIV and early life stress on amygdala morphometry and neurocognitive function.Drug abuse and hepatitis C infection as comorbid features of HIV associated neurocognitive disorder: neurocognitive and neuroimaging featuresMapping mental number line in physical space: vertical and horizontal visual number line orientation in asymptomatic individuals with HIV.Increases in brain white matter abnormalities and subcortical gray matter are linked to CD4 recovery in HIV infectionGlobal gray and white matter metabolic changes after simian immunodeficiency virus infection in CD8-depleted rhesus macaques: proton MRS imaging at 3 T.Disrupted cerebral metabolite levels and lower nadir CD4 + counts are linked to brain volume deficits in 210 HIV-infected patients on stable treatmentFrailty Characteristics in Chronic HIV Patients are Markers of White Matter Atrophy Independently of Age and Depressive Symptoms: A Pilot Study.Regional brain gray and white matter changes in perinatally HIV-infected adolescents.Altered structural brain changes and neurocognitive performance in pediatric HIV.Accelerated aging of selective brain structures in human immunodeficiency virus infection: a controlled, longitudinal magnetic resonance imaging study.Increased subcortical neural activity among HIV+ individuals during a lexical retrieval task.Regionally Specific Brain Volumetric and Cortical Thickness Changes in HIV-Infected Patients in the HAART Era.The effects of HIV and aging on subcortical shape alterations: A 3D morphometric study.Larger Subcortical Gray Matter Structures and Smaller Corpora Callosa at Age 5 Years in HIV Infected Children on Early ART.Brain Structural Changes following HIV Infection: Meta-Analysis.
P2860
Q24617094-46801D34-883D-48E0-826E-9EC4A7314330Q26852705-25AA8BF3-FFDA-4236-88AB-085427DF0F7FQ30854917-010B63D1-2E55-4B63-863D-D271829608E0Q30936809-98898EA1-46A7-4A05-B3D3-D6035DCE1080Q34596492-CBC8D232-3BAE-4505-B2BB-422742C77196Q34684219-3E05A191-A521-413C-83B8-D02804B222A8Q34694713-E601A6F6-9418-4FF5-9A4F-21C2A0B2F822Q34714684-F07963D2-5BF2-4022-973C-1EFDF9E39B39Q34787585-57A007D1-907A-43A1-9A94-658787CAB999Q34862412-8C11ED16-4D48-40B9-BEBE-9681F2DEEA7CQ35241519-89AFF3A7-B8E3-4A60-8D5F-AC20E1445C6BQ35852479-5FC69B69-7553-430E-BCA1-88DFAB7D3FF1Q36081701-34CF4D38-6198-4CCC-BDB2-383754312E75Q36087139-F926F97C-28E1-472A-8369-4CAF31C553A4Q36607785-E4EBB675-21F6-4D31-97EB-6E8B879413E2Q36619628-B624F28A-FD5C-4B75-884C-F41C45FF327BQ36792636-5ADF50C4-E191-4C5E-A84F-168974816E58Q37010286-5ADE5F60-79B7-4FA8-8BE0-8077FF9D3317Q37181324-B3636CD4-1633-4C6F-A33F-2AF6825BF760Q37201040-58E8EE3C-0887-4921-A358-9FA84B5C9F38Q37217155-419B80EE-BD95-4E2A-A7C3-54EE453D2056Q37313204-F4DBE5A7-6F94-405E-886A-0A5D5F317D10Q37417723-A79298EF-2527-4856-B9B2-B8C5C7EE9255Q37638105-BDEE6B14-C50D-4613-A67F-F5B41313F55EQ37692750-0D86C459-F5F5-4E6F-8B4F-60A485A5355DQ38401668-3164B3CE-A3FA-45B0-B743-D1A236620819Q40355941-84D588F9-CEF7-4A83-81DC-CA4C920D2D8CQ40486706-D660F2E2-49D5-41CB-9355-D114A25415F0Q47201399-D3236FC2-45FE-4964-B5A7-A36124FA29FCQ47666097-8F8B72F1-E6E9-4563-BCF8-2C7D1035AFB8
P2860
Putamen hypertrophy in nondemented patients with human immunodeficiency virus infection and cognitive compromise.
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Putamen hypertrophy in nondeme ...... tion and cognitive compromise.
@ast
Putamen hypertrophy in nondeme ...... tion and cognitive compromise.
@en
Putamen hypertrophy in nondeme ...... tion and cognitive compromise.
@nl
type
label
Putamen hypertrophy in nondeme ...... tion and cognitive compromise.
@ast
Putamen hypertrophy in nondeme ...... tion and cognitive compromise.
@en
Putamen hypertrophy in nondeme ...... tion and cognitive compromise.
@nl
prefLabel
Putamen hypertrophy in nondeme ...... tion and cognitive compromise.
@ast
Putamen hypertrophy in nondeme ...... tion and cognitive compromise.
@en
Putamen hypertrophy in nondeme ...... tion and cognitive compromise.
@nl
P2093
P1433
P1476
Putamen hypertrophy in nondeme ...... tion and cognitive compromise.
@en
P2093
Chantal E Stern
J Mimi Boer Castelo
Maureen G Courtney
Rebecca J Melrose
P304
P356
10.1001/ARCHNEUR.64.9.1275
P577
2007-09-01T00:00:00Z